FDA reviewing new type of experimental insomnia drug that could be a blockbuster for Merck

  • by: The Associated Press , Associated Press
  • Updated: November 8, 2012 - 11:49 AM

WHITEHOUSE STATION, N.J. - Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its experimental insomnia medication, suvorexant (SOO'vor-eks-ant).

  • 0
  • Comments

There are currently no comments for this article

Comment on this story   |   Be the first to comment

Be the first to comment

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT